Related Experiment Video
Updated: Oct 14, 2025
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Cancer vaccines from cryogenically silicified tumour cells functionalized with pathogen-associated molecular patterns
Jimin Guo1, Henning De May2, Stefan Franco1
1Department of Internal Medicine, University of New Mexico Health Science Center, Albuquerque, NM, USA.
Abstract:
The production of personalized cancer vaccines made from autologous tumour cells could benefit from mechanisms that enhance immunogenicity. Here we show that cancer vaccines can be made via the cryogenic silicification of tumour cells, which preserves tumour antigens within nanoscopic layers of silica, followed by the decoration of the silicified surface with pathogen-associated molecular patterns. These pathogen-mimicking cells activate dendritic cells and enhance the internalization, processing and presentation of tumour antigens to T cells. In syngeneic mice with high-grade ovarian cancer, a cell-line-based silicified cancer vaccine supported the polarization of CD4+ T cells towards the T-helper-1 phenotype in the tumour microenvironment, and induced tumour-antigen-specific T-cell immunity, resulting in complete tumour eradication and in long-term animal survival. In the setting of established disease and a suppressive tumour microenvironment, the vaccine synergized with cisplatin. Silicified and surface-modified cells from tumour samples are amenable to dehydration and room-temperature storage without loss of efficacy and may be conducive to making individualized cancer vaccines across tumour types.
Insights
This study introduces a novel method for creating personalized cancer vaccines using silicified tumor cells. This approach enhances immune response, leading to complete tumor eradication and long-term survival in mice.
Area of Science:
- Oncology
- Immunology
- Materials Science
Background:
- Personalized cancer vaccines require enhanced immunogenicity.
- Current methods for autologous tumor cell vaccines have limitations.
Purpose of the Study:
- To develop a novel method for producing effective personalized cancer vaccines.
- To investigate the immunogenicity and efficacy of silicified tumor cell vaccines.
Main Methods:
- Cryogenic silicification of tumor cells to preserve antigens within silica layers.
- Surface decoration with pathogen-associated molecular patterns to mimic pathogens.
- Evaluation of vaccine efficacy in syngeneic mouse models of ovarian cancer.
Main Results:
- Silicified cancer vaccines activated dendritic cells and enhanced T cell-mediated tumor antigen presentation.
- Vaccination promoted CD4+ T cell polarization towards a T-helper-1 phenotype.
- Complete tumor eradication and long-term survival were achieved in mice.
- The vaccine synergized with cisplatin in established disease settings.
- Silicified cells demonstrated stability for dehydration and room-temperature storage.
Conclusions:
- Cryogenic silicification offers a promising strategy for developing potent personalized cancer vaccines.
- This method preserves tumor antigens and enhances anti-tumor immunity.
- The technology is adaptable for various tumor types and facilitates storage and transport.
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
01:51Vaccinations